Analysis: He Went to Prison for Gene-Editing Babies. Now Hes Planning to Do It Again

The Controversial Path of China's Gene-Editing Pioneer

In a scientific first, He Jiankui, a Chinese researcher, created gene-edited babies in 2018, sparking global debate and landing him in prison. Now, three years later, he is back, aiming to change the world with his gene therapy research.

A Second Chance at Gene Editing

Since his release from prison in 2022, He Jiankui has been working on a gene therapy for boys with Duchenne muscular dystrophy. Despite a lack of public results, he claims that a pharmaceutical company has taken on his research and that funders are eager to support him. His new focus is on human embryo editing, this time to prevent Alzheimer's disease.

The Road Ahead for Gene-Edited Babies

With germline editing prohibited in nearly every country, including the United States, He's path forward is unclear. He has set his sights on South Africa, which removed language from its national ethics guidelines potentially allowing heritable human genome editing in 2025. However, he faces challenges, including obtaining regulatory approval and securing funding.

Implications for North East India and Beyond

The developments in gene editing have significant implications for the broader Indian context, including the North East region. As research progresses, ethical questions around the use of gene editing for disease prevention and potential enhancement will become increasingly important. India, with its rich genetic diversity and large population, may find itself at the forefront of these debates.

Reflections and the Future of Gene Editing

He Jiankui's journey serves as a reminder of the potential benefits and risks associated with gene editing. As the technology continues to evolve, it is crucial to strike a balance between pushing the boundaries of science and ensuring the ethical treatment of all individuals involved.